• Dextromethorphan Hydrobromide: A New Horizon for Translation

  2026-07-03

  This thought-leadership article examines the mechanistic and strategic value of Dextromethorphan hydrobromide as an NMDA receptor antagonist in neuroprotection research. It addresses the biological underpinnings of excitotoxicity, offers actionable guidance for experimental design, and contextualizes this molecule within the evolving landscape of translational neuroscience and metabolic disease models. Integrating evidence from recent advances, the article positions Dextromethorphan hydrobromide as a pivotal tool for researchers aiming to bridge preclinical promise with clinical impact.

• Cy3 TSA Fluorescence System Kit: Workflow Advances & Signal

  2026-07-03

  The Cy3 TSA Fluorescence System Kit empowers researchers to detect low-abundance proteins and nucleic acids in tissue and cell samples with unmatched sensitivity. Integrating APExBIO’s robust tyramide signal amplification chemistry and streamlined protocols, this system enables high-density fluorescent labeling for immunohistochemistry, immunocytochemistry, and in situ hybridization—where traditional detection methods fall short.

• Nelfinavir Mesylate: Catalyzing Translational Research at th

  2026-07-02

  This in-depth, evidence-backed article explores how Nelfinavir Mesylate, a potent HIV-1 protease inhibitor, is redefining translational research by bridging antiviral discovery and ferroptosis modulation. Through mechanistic insight, experimental guidance, and strategic foresight for cross-domain innovators, we chart new territories beyond conventional antiretroviral paradigms. Featuring the latest findings on the DDI2-NFE2L1-proteasome axis and practical workflow advice, this guide equips researchers to leverage Nelfinavir Mesylate in advanced HIV infection research, cell death assays, and therapeutic development.

• Rewriting Sensitivity: Cy3 TSA Fluorescence Kit for Translat

  2026-07-02

  This article offers strategic, mechanistic, and competitive insights for translational researchers seeking to surmount the challenge of detecting low-abundance biomolecules. By dissecting the molecular logic of tyramide signal amplification and recent advances in olfactory receptor biology, we illuminate how the Cy3 TSA Fluorescence System Kit (APExBIO) sets new standards in fluorescence microscopy detection, guiding researchers toward next-generation experimental rigor.

• Actinomycin D in Chemoresistance: Mechanistic Insights for C

  2026-07-01

  Explore the advanced mechanisms by which Actinomycin D modulates chemoresistance and apoptosis induction in cancer research. This article provides a unique, in-depth analysis linking ActD’s role in transcriptional inhibition to novel ferroptosis pathways.

• Hydroxyl Radical Degradation of Dimetridazole: Mechanisms &

  2026-07-01

  This study delivers a detailed quantum chemical analysis of how hydroxyl radicals degrade Dimetridazole (1,2-Dimethyl-5-nitroimidazole) and related nitroimidazoles in water. The findings clarify degradation kinetics, reveal intermediate toxicities, and inform safer environmental remediation strategies.

• FITC Goat Anti-Rabbit IgG (H+L): Signal Amplification Redefi

  2026-06-30

  Explore how the FITC Goat Anti-Rabbit IgG (H+L) Antibody enables next-generation signal amplification for immunoassays. This article delves into its biochemical mechanism, advanced assay applications, and recent scientific advances that shape practical detection workflows.

• Quinolone–Coumarin Hybrids Show Selective Activity Against T

  2026-06-30

  A recent in vitro study demonstrates that novel quinolone–coumarin hybrids, derived from fluoroquinolone antibiotics and novobiocin, exhibit selective anti-Toxoplasma gondii activity with reduced host cell toxicity. These findings highlight the therapeutic potential of hybrid scaffolds over classical antiparasitic agents, informing rational drug design for toxoplasmosis.

• Drug-Sensitized Yeast as a Platform for mTOR Inhibitor Disco

  2026-06-29

  This study establishes a highly sensitive yeast-based screening platform for the discovery of mTOR inhibitors, substantially improving detection thresholds for known compounds. The findings clarify the specificity boundaries of candidate molecules, including Nebivolol hydrochloride, in mTOR pathway research.

• TRIM66 Controls Monogenic Olfactory Receptor Expression in O

  2026-06-29

  This study uncovers TRIM66 as a critical epigenetic repressor enabling monogenic and monoallelic olfactory receptor expression in mature olfactory sensory neurons (OSNs). The findings bridge a longstanding gap in understanding how single neurons select and maintain expression of just one receptor gene, with broad implications for sensory neuroscience and epigenetic regulation.

• Verbascoside: Advanced Insights into PKC/NF-κB Inhibition in

  2026-06-28

  Explore how Verbascoside, a leading PKC/NF-κB inhibitor, enables advanced modeling of neuroinflammatory mechanisms and osteoclastogenesis. This article reveals new experimental strategies and cross-talk insights that differentiate it from standard cell signaling coverage.

• YTHDF2-ACSL4 Axis Drives Ferroptosis in Diabetic Wound Heali

  2026-06-27

  This study uncovers how YTHDF2 regulates ACSL4-dependent ferroptosis in keratinocytes, directly linking ferroptotic cell death to impaired diabetic wound healing. These findings highlight ferroptosis as a promising therapeutic target for improving skin regeneration in diabetes.

• Indole Analogue Tc3 Induces Pyroptosis in Hepatic Carcinoma

  2026-06-26

  This study identifies the indole-derived compound Tc3 as a potent inducer of pyroptosis in hepatic carcinoma cells, acting via gasdermin E activation and endoplasmic reticulum stress. Tc3 not only suppresses tumor growth but also enhances the efficacy of cisplatin and anti-PD-1 therapies, offering a synergistic approach to improve hepatic carcinoma treatment.

• Co-Targeting BRD4 and RAC1 Disrupts c-MYC Axis in Breast Can

  2026-06-26

  This study introduces a combined therapeutic strategy targeting BRD4 and RAC1 in diverse subtypes of breast cancer. By disrupting the c-MYC-G9a-FTH1 axis and downregulating HDAC1, the approach suppresses tumor growth and stemness, offering mechanistic insight and potential translational value.

• CAY10499: Inhibitor of Human Hormone Sensitive Lipase for Li

  2026-06-25

  CAY10499 stands out as a precision inhibitor of human hormone sensitive lipase and monoglyceride lipase, enabling high-fidelity lipid metabolism and immunometabolic assays. This article details applied protocols, troubleshooting guidance, and insight from reference studies to empower advanced research into metabolic regulation and disease.

16078 records 1/1072 page Next 12345 下5页 Last page